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Purpose: To determine postoperative morbidity (POM) in patients undergoing surgery for uncomplicated
hepatic echinococcosis (HE) and determine associations with the variable POM looking for possible risk
factors for POM.
Methods: Nested case-control study. We included patients undergoing surgery for uncomplicated HE in
two hospitals in Temuco between 2000 and 2012. The main outcome variable was development of POM.
Other variables of interest were hospital stay, mortality and recurrence. Surgical techniques used were
pericystectomy and liver resection. Descriptive statistics and analytical statistics were applied using T-
test, ANOVA and KruskaleWallis test to compare continuous variables; Chi2 and Fisher’s exact test for
categorical variables, and logistic regression models were used, estimating OR.
Results: 126 patients, median age 41 years, 61% female. The incidence of POM was 10.3%, with 76.9%
Clavien grade I or II. The etiology was 6.5% and 4.1% of medical and surgical complications, respectively.
There was no mortality and with a median follow-up of 83 months, recurrence incidence was 0.8%.
Association was found between cases and controls and the variables age, alkaline phosphatase, cyst
location and hospital stay. Applying regression models age (p ¼ 0.002 and OR 1.07) and cyst location
(p ¼ 0.003 and OR 3.94) were found to be risk factors.
Conclusions: Observed POM is lower and of less severity than those previously published. Risk factors
were determined.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Echinococcosis is a zoonotic disease endemic in southern Chile,
which is associated with the need to treat a considerable number of
new cases of hepatic echinococcosis (HE) per year promptly and
effectively.
While still a prevalent health problem in some areas of the
world, the scientiﬁc literature on HE surgery is not as large, with
some confusion and controversy persisting concerning morbidity
of surgery for HE. Reports of this variable did not change substan-
tially over time regardless of where the data were generated. In
articles from the 1990s postoperative morbidity (POM) values of
34.7%e62.5% were reported [1e3]. After 2000, the situation did notulty of Medicine, Universidad
o, Chile.
Manterola).
by Elsevier Ltd. All rights reservedseem to improve substantially because POM values from 21.3% to
53.8% were still being published [4e12], and in the last ﬁve years
from 1.2% to 79.9% [13e17], with a median value of 33.0%. This
situation could be explained by the heterogeneity of the pop-
ulations analyzed in the different studies, which included patients
with complicated and non-complicated HE, and different forms of
assessment of the variable POM.
A few years ago, we reported the POMof a series of patients with
non-complicated HE using the proposal by Dindo and Clavien
[18,19], and with a median follow up of 96 months we veriﬁed 8.6%
overall POM [20]. Therefore, we proposed that potential associa-
tions between POM and other clinical variables be measured and
that possible risk factors be examined.
The aim of this study was to determine POM in patients un-
dergoing surgery for uncomplicated HE and determine associations
with the variable POM looking for possible risk factors for POM..
C. Manterola et al. / International Journal of Surgery 12 (2014) 695e699696This manuscript was prepared according to the STROBE state-
ment for reporting observational studies [21].
2. Methods
2.1. Study design
Nested caseecontrol study.
2.2. Setting
The study was performed in the Surgery Department of the
Universidad de La Frontera (Temuco, Chile). Patients undergoing
surgery by the surgical services of Hernan Henríquez Aravena
hospital and the Universidad Mayor Clinic in Temuco, Chile from
April 2000 to April 2012 were recruited.
2.3. Participants
Patients undergoing surgery for non-complicated HE by the ﬁrst
author were included (Fig. 1). Laparoscopically operated patients,
subjects with concomitant echinococcosis in another location, pa-
tients with previous surgery for HE and those with evolutionary
complications were excluded. "Cases" were deﬁned as those pa-
tients operated on for non-complicated HE who developed POM
and "controls" as those patients operated on for HE who did not
develop POM during the follow-up period.
2.4. Variables
The main outcome variable was overall POM. Other variables of
interest were age, gender, morbid antecedents, laboratory tests,
ultrasonography ﬁndings, location, number and diameter cysts,
presence of bile communications, type of surgery performed, hos-
pital stay, reoperation rate, mortality and recurrence.s
2.5. Data sources/measurements
Overall POM was seen as a dichotomous variable (no/yes), then
categorized by source (none/medical/surgical) and ﬁnally by its
severity applying Dindo and Clavien [18,19] for which a minimum
of 12 months’ follow-up is required.
2.6. Deﬁnitions
Non-complicated HE was deﬁned as pure HE, i.e., not associated
with evolutionary complications such as liver abscess [22,23],Fig. 1. Image of non-complicated HE located in the center of the liver.hepatothoracic transit [24], colangiohidatidosis [25,26], hydatid
peritonitis [27], anaphylaxis, ﬁstulization of the cyst to some
digestive structure and the existence of concomitant locations of
the disease [27].
2.7. Study protocol
A data collection sheet was drawn up and in it biodemographic
and clinical characteristics of the patients, laboratory and imaging
ﬁndings, characteristics of the cysts, surgical aspects and post-
operative course in terms of POM, need for reoperations, mortality
and recurrence were recorded.
2.8. Follow-up protocol
A clinical check was made with general laboratory tests, deter-
mination of speciﬁc immunoglobulins (ELISA-IgG and ELISA-IgE)
[28,29], thoracic x-ray and abdominal ultrasound at 1, 6 and 12
month, and from then one a year postoperatively for a minimum of
5 years.
2.9. Bias
Efforts to address potential sources of bias were the following:
The complete follow-up of the cohort allowed us to work with
incident cases and controls. Controls also came from the same
population from which the cases were selected, so they had the
same potential for exposure as the cases. Finally, data were
collected by researchers other than the one who performed the
surgeries (TO, SU).
2.10. Study size
This was not considered because the entire target population
was included.
2.11. Statistical methods
We performed an exploratory analysis of the data, after which
descriptive statistics were used to calculate percentages and mea-
sures of central tendency and dispersion (mean ± standard devia-
tion, median and extreme values). Then the incidence or absolute
risk (AR) of POM was determined, and then statistical analysis was
conducted, using t-test, ANOVA and the KruskaleWallis test for
comparison of continuous variables, and Chi2 and Fisher’s exact
test for categorical variables. Finally, logistic regression models
estimating OR and their respective 95% conﬁdence intervals (CI
95%) were applied.
2.12. Ethics
The study was approved by the ethics committee of the Faculty
of Medicine at the Universidad de La Frontera and every patient
signed an informed consent.
3. Results
In the study period a total of 276 patients with HEwere operated
on and treated according to this scheme, of which, when the se-
lection criteriawere applied,126 patients remained (Fig. 2), with no
losses of follow-up.
The average age of the participants was 41 (15e84 years); and
60.3% of them (76 cases) were female. Thirty-nine patients (30.9%)
were carriers of some associated pathology, of which cholelithiasis
was predominant (21 cases; 16.7%). See Table 1.
Fig. 2. Flow chart of the study participants.
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various size and location in the hepatic parenchyma. The median of
the diameter of all the cysts was 15.0 cm (5e30 cm) as determined
by ultrasonography. The lesions tended to be located in the right
lobe (61.9%) and had a hypoechogenic pattern at ultrasonography in
61.9% of the cases.
The most frequently used surgical procedure was peri-
cystectomy (85.7%). 32.6% of patients had two or more cysts, and
61.1% of the main cysts had evident bile communications. In 76.2%
of the cases, some other surgical procedure was performed
concomitantly. The laboratory studies highlighted the increased
value of the median in the determination of alkaline phosphatases.
The median of the hospital stay was 4 days. With a follow-up
median of 83 months (12e144 months), an RA of overall POM
(cases) was 10.3% (13 patients of the total throughout the entire
follow-up period); 76.9% of the cases were Clavien grade I or II.
Speciﬁc complications of HE surgery were seen in 3.9%. Only the
patients with eventration (2 cases) required re-operation, which
represents a re-operation incidence of 1.6%. See Table 2.
The median of hospitalization time was 4 days (2e17 days). No
mortality was recorded; recurrence was veriﬁed in 1 patient, which
represents an RA of 0.8%.Table 1
Associated comorbidity in patients under study (n ¼ 126).
Variable N cases %
Associated pathology (%)
No pathology 87 69.0
Cholelithiasis 21 15.9
Cardiopathy 5 3.9
CAL 4 3.2
Hepatic cirrhosis 2 1.6
Pregnancy (*) 2 1.6
Cardiopathy þ DM 1 0.8
Others (**) 5 4.0
CAL: Chronic airﬂow limitation.
DM: Diabetes Mellitus.
(*): Both cases of pregnancy were treated in the ﬁrst trimester.
(**): Epilepsy, chronic renal failure, diabetes Mellitus type II, abdominal trauma (one
case of each); and one patient with cholelithiasis and concomitant hepatic cirrhosis.
In the patient with abdominal trauma, the HE was an intraoperative ﬁnding and was
resolved during the same operation.When the cohort was divided into cases and controls and
bivariate analyses were applied, association of the variable POM
between cases and controls was determined with the variables age,
alkaline phosphatase, location of the cyst (greater frequency of
centro-hepatic and bilateral for cases than controls) and hospital
stay (Tables 3 and 4).
Logistic regression models veriﬁed the association of the vari-
able development of POM between cases and controls with the
variables age, with a value of p ¼ 0.002 and an OR of 1.07 (CI 95%
1.02 1.12); and location of the main lesion, with a value of p¼ 0.003
and an OR of 3.94 (CI 95% 1.59 9.78).
4. Discussion
We can say that the key is the overall POM described in patients
with non-complicated HE (10.3%), less than what has been pub-
lished and with a low level of severity, as well as the ﬁnding of risk
factors for overall POM (the variables age and cyst location).
With respect to the limitations of the study, we can say that the
low overall POM found is a disadvantage from the statistical point
of view, since the type of research design used requires a compar-
ison between the cases (n ¼ 13) and the controls (n ¼ 113), a sit-
uation which, given the inequality of the groups being compared,Table 2
Morbidity in patients under study (n ¼ 126).
Variable N cases %
Clavien
Grade 0 113 89.7
Grade I 5 4.0
Grade II 5 4.0
Grade IIIb 3 4.3
Morbidity
No 113 89.7
Atelectasis 6 4.7
SSI (*) 2 1.6
Eventration 2 1.6
UTI (**) 1 0.8
Cardiac arrhythmia (***) 1 0.8
Residual cavity 1 0.8
(*): Surgical site infection.
(**): Urinary tract infection.
(***): Supraventricular tachyarrhythmia.
Table 3
Continuous variables. Comparison between cases and controls.
Variable Cases (n ¼ 13) Controls (n ¼ 113) p
Age (years) 59.1 ± 18.8 41.3 ± 16.3 0.0004
Cyst diameter (cm.) 16.4 ± 5.8 14.8 ± 5.8 0.3328
Hospital stay (days) 9.2 ± 6.5 4.1 ± 1.9 0.003
Hematocrits (%) 38.9 ± 3.6 39.8 ± 4.2 0.4746
Leukocytes (9 mm3) 7933.3 ± 2510.1 8516.2 ± 2799.0 0.4355
Total bilirubin (mg/dL) 1.0 ± 0.3 1.0 ± 0.2 0.9654
Alkaline phosphatase (U/l) 406.2 ± 317.1 690.0 ± 969.0 0.0257
ASAT (U/l) 62.8 ± 105.5 35.7 ± 34.8 0.3965
ALAT (U/l) 65.2 ± 93.6 38.1 ± 49.5 0.0964
Table 4
Categorical variables. Comparison between cases and controls.
Variable Cases (n ¼ 13) Controls (n ¼ 113) p
Gender (%)
Women 46.2 61.9 0.247
Men 53.8 38.1
Ultrasound characteristics of the cyst (*)
Hypoechoic 38.5 65.1 0.104
Heterogeneous 61.5 32.5
Hyperechogenic (solid) 0.0 2.4
Location of the cyst (*)
Right lobe 30.8 65.9 0.006
Left lobe 23.1 20.6
Bilateral and centro-hepatic 46.2 13.5
Number of cysts
One 46.1 69.8 0.111
Two or more 53.9 30.2
Bile communications
None 30.8 39.7 0.811
One 38.4 36.5
Two or more 30.8 23.8
Surgery performed on the main lesion (*)
Pericystectomy 84.6 85.7 0.185
Hepatic resection 15.4 14.3
Treatment of the residual cavity
No treatment (no residual
cavity remained)
53.9 38.9 0.533
Capitonnage 15.4 30.2
Omentoplasty 30.7 30.9
Concomitant surgeries
None 30.8 23.0 0.916
Cholecystectomy 53.8 61.1
Others 15.4 15.9
(*): Refers to the main lesion in those patients who had two or more cysts.
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tween cases and controls with the other variables of interest.
However, the nested caseecontrol study as a special cohort study is a
design type suitable to the evaluation of prognostic aspects because
it contributes a good level of evidence [30] and also has some ad-
vantages, including cost-efﬁciency, high validity, and analytic ﬂexi-
bility [31]. As far as we know, it is the only study referring to this
subject, inwhich this type of design has been used and inwhich the
variable of interest has been measured by applying the proposal by
Dindo and Clavien [19,20]. This is an interesting ﬁnding because, on
the one hand, age appears again as a risk factor for POM, as we
reported in a previous article [29], inwhich the cut-off point was 45
years of age; and on the other because the centro-hepatic and
bilateral location appears as a risk factor with an OR of 3.94, which
is interpreted as there being 4 times the likelihood that a post-
operative complication will develop in patients with centro-
hepatic and bilateral HE than in subjects with HE located in the
lateral segments of the right or left lobe.
As previously mentioned, the publications related to HE surgery
are relatively few and with a low level of evidence; thus, a search in
the MEDLINE database using the MeSH terms "Echinococcosis,Hepatic/surgery"[Mesh], produced 2013 records. Reﬁning through
the NOT Boolean operator (“alveolar echinococcosis”, “pulmonary
echinococcosis”, “lung echinococcosis”, “pharmacological treat-
ment”, “laparoscopic surgery”) produced 1627 andwith some limits
(articles published fromApril 1999 to the date of the review [15/04/
2013], in the human adult population; and in Spanish, English and
French), it was narrowed to 430 articles. Now,whenwe added limits
related to the design type of the articles seeking the best level of
evidence (clinical trials, randomized controlled clinical trials, sys-
tematic reviews and meta-analysis), the search only generated 25
articles. This means that in the last 15 years more than 95% of the
articles referring toHE surgery continue to be series of cases,most of
which contain a heterogeneous population and therefore results the
internal and external validity of which is objectionable.
In light of the foregoing, one of the permanent dilemmas despite
the technological progress is morbidity in HE surgery. It is worthy of
note that in the last 10 years approximate ﬁgures of 16% to a 80%
have continued to be reported [6e18], particularly if analyzed from
the point of view of dealing with a benign disease. It is possible that
these ﬁgures, which seem out of proportion and dispersed, are
related to the heterogeneity of the study populations because, as
previously indicated, patients with complicated and non-
complicated HE are mixed together, operated on with different
techniques and their respective variants and in centers with various
levels of experience in this type of surgery.
It should also be mentioned that the objectivized co-morbidity
(30.9% of the cases) may in some way affect the development of
POM, particularly if this includes on the one hand the 14.3% related
to medical co-morbidity, and on the other what caused the need to
perform concomitant surgeries (23.8% of the 93 cases in which this
occurred).
Another aspect of interest: despite being non-complicated HE,
little more than one quarter of the patients had more than two bile
communications, a fact that we have shown to be associated with
an increase in POM [27].
The median of the hospital stay was 4 days, which contrasts
with the previously published data that range between 5 and 16
days [7,8,10,13,18,32e35].
The observed incidence of overall POM (10.3%) seems to us
adequate in relation to previous studies because in the last 4 years
numbers between 16.2% and 79.9% have been reported
[7,9e11,13e18], above all because the severity of the complications
is mainly low and only in 40.0% of the cases with surgery with an
incidence of re-operation (1.6%), lower than reported (5.2 a 12.0%
[12e14]), despite the extensive follow-up period (median of 83
months) that exceeds most of the previous reports.
Additionally, the recurrence incidence (0.8%) also contrasts
with previous ﬁgures that range between 1.2% and 30.4%
[6,10,12,14,16,33,36e38].
Finally, the absence of mortality in this cohort is highlighted
when compared to other series where the ﬁgures vary between
0.3% and 9.2% [6,8e11,15e17,36,37,39,40].
With respect to the external validity of the study results, it can
be mentioned that these results will be generalizable every time
patients are operated on in centers with experience in HE surgery.
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